SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 162 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $359,000 | -87.5% | 27,700 | -81.9% | 0.02% | -79.0% |
Q3 2016 | $2,863,000 | +132.8% | 152,800 | +205.6% | 0.10% | -13.9% |
Q2 2016 | $1,230,000 | +137.9% | 50,000 | -70.0% | 0.12% | +134.6% |
Q1 2016 | $517,000 | +27.0% | 166,400 | +154.6% | 0.05% | +126.1% |
Q3 2014 | $407,000 | – | 65,364 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |